The European Medicines Agency has recommended the authorization of two new medicines against the coronavirus for people at risk of severe disease.
In a statement on Thursday, the EU drug regulator said it had concluded that the monoclonal antibody treatments -- a combination of casirivimab and imdevimab, and the drug regdanvimab -- have both been proven to significantly reduce the risk of hospitalization and death in patients vulnerable to serious COVID-19.
Read more at:
EU authorizes 2 medicines for people at risk of severe COVID-19 | CTV News
ANNUAL ADVERTISING RATES FOR INSURE-DIGEST
Showing posts with label Vaccines. Show all posts
Showing posts with label Vaccines. Show all posts
Thursday, November 11, 2021
Wednesday, August 11, 2021
Vaccines give COVID-19 survivors a big immune boost, studies show
According to a new Gallup survey, one of the main reasons Americans cite for not planning to get vaccinated is the belief that they're protected since they already had COVID-19.
From the beginning health authorities have urged survivors to get the broader protection vaccination promises. While the shots aren't perfect, they are providing strong protection against hospitalization and death even from the delta mutant.
Read moreat: Vaccines give COVID-19 survivors a big immune boost, studies show | CBC News
From the beginning health authorities have urged survivors to get the broader protection vaccination promises. While the shots aren't perfect, they are providing strong protection against hospitalization and death even from the delta mutant.
Read moreat: Vaccines give COVID-19 survivors a big immune boost, studies show | CBC News
Labels:
Coronavirus,
Revie,
Vaccines
Saturday, July 24, 2021
COVID-19 vaccine inequity: Inside the cutthroat race to secure doses
No one disputes that the world is unfair. But no one expected a vaccine gap between the global rich and poor that was this bad, this far into the pandemic.
Inequity is everywhere: Inoculations go begging in the United States while Haiti, a short plane ride away, received its first delivery July 15 after months of promises - 500,000 doses for a population over 11 million. Canada has procured more than 10 doses for every resident; Sierra Leone's vaccination rate just cracked 1% on June 20.
It's like a famine in which “the richest guys grab the baker,” said Strive Masiyiwa, the African Union's envoy for vaccine acquisition.
In fact, European and American officials deeply involved in bankrolling and distributing the vaccines against coronavirus have told The Associated Press there was no thought of how to handle the situation globally. Instead, they jostled for their own domestic use.
For the complete detailed report go to: COVID-19 vaccine inequity: Inside the cutthroat race to secure doses | CP24.com
Inequity is everywhere: Inoculations go begging in the United States while Haiti, a short plane ride away, received its first delivery July 15 after months of promises - 500,000 doses for a population over 11 million. Canada has procured more than 10 doses for every resident; Sierra Leone's vaccination rate just cracked 1% on June 20.
It's like a famine in which “the richest guys grab the baker,” said Strive Masiyiwa, the African Union's envoy for vaccine acquisition.
In fact, European and American officials deeply involved in bankrolling and distributing the vaccines against coronavirus have told The Associated Press there was no thought of how to handle the situation globally. Instead, they jostled for their own domestic use.
For the complete detailed report go to: COVID-19 vaccine inequity: Inside the cutthroat race to secure doses | CP24.com
Labels:
3e World,
Covid-19,
Cuthroat,
Disparity,
industrialized,
Power Play,
Vaccines
Tuesday, July 6, 2021
EU says it plans more COVID-19 vaccine donations as world faces two-track pandemic
John Ryan, a senior European Commission health official, told a briefing that the bloc hoped to donate a further 100 million doses of COVID-19 vaccines to low and middle income countries by year-end, using the COVAX facility as the main channel.
Read more at: EU says it plans more COVID-19 vaccine donations as world faces two-track pandemic
Read more at: EU says it plans more COVID-19 vaccine donations as world faces two-track pandemic
Labels:
Donate,
EU,
Global needs,
Towards,
Vaccines
Monday, June 28, 2021
Coronavirus patents: India, South Africa bid to ban COVID vaccine patents finds few takers in Latin America
In May, India and South Africa called on the World Trade Organization (WTO) to temporarily waive intellectual property (IP) rules related to COVID-19 vaccines, medicines, diagnostics and other technologies.
The draft was co-sponsored by more than 60 countries that had warmed up to the idea. It was initially proposed in October last year amid snail-paced vaccine deliveries during the pandemic as rich countries cornered the bulk of the supplies.
Read more at: India, South Africa bid to ban COVID vaccine patents finds few takers in Latin America | Business| Economy and finance news from a German perspective | DW | 28.06.2021
The draft was co-sponsored by more than 60 countries that had warmed up to the idea. It was initially proposed in October last year amid snail-paced vaccine deliveries during the pandemic as rich countries cornered the bulk of the supplies.
Read more at: India, South Africa bid to ban COVID vaccine patents finds few takers in Latin America | Business| Economy and finance news from a German perspective | DW | 28.06.2021
Labels:
Coronavirus,
patents,
Vaccines
Wednesday, June 9, 2021
Vaccines: COVID-19 Vaccines Are Better Than We Ever Expected
Amid a global tragedy, the striking effectiveness of vaccines against the coronavirus stands out as one of the pandemic’s few good-news stories for humanity.
And the vaccines are the success story that, so far, has kept on going. Vaccinations are proving to be just as effective in the real world as they were in clinical trials, while remaining highly protective against the more contagious variants spreading worldwide. And two recent studies found that immunity to the virus could last for years.
Read more at: COVID-19 Vaccines Are Better Than We Ever Expected
And the vaccines are the success story that, so far, has kept on going. Vaccinations are proving to be just as effective in the real world as they were in clinical trials, while remaining highly protective against the more contagious variants spreading worldwide. And two recent studies found that immunity to the virus could last for years.
Read more at: COVID-19 Vaccines Are Better Than We Ever Expected
Labels:
Good Results,
Immunity,
Studies,
Vaccines
Thursday, May 13, 2021
Netherlands - Calvinists: In the Netherlands, traditional Calvinists refuse vaccines and social distancing
In the Netherlands, Protestants make up around 16 percent of the population and a small group of traditional Calvinists are opposed to vaccination and social distancing. Most of these believers, who live in a region known as the "Bible Belt", were never vaccinated as children and are opposed to the idea of injecting sickness into a healthy body. Despite surging case numbers, they continue to attend Sunday services without face masks. But amid some of the country's highest Covid-19 infection rates, some of them are starting to shift their mindset. Our regional correspondents report.
Read more at: In the Netherlands, traditional Calvinists refuse vaccines and social distancing - Focus
Read more at: In the Netherlands, traditional Calvinists refuse vaccines and social distancing - Focus
Labels:
Calvinists,
Object,
The Netherlands. Religion,
Vaccines
Friday, February 5, 2021
EU: In Europe Union, vaccines from Russia and China are now under study - by Loveday Morris
As the European Union's vaccination program stumbles, Russia and China are poised to fill the gap — with Moscow opening talks to produce vaccines in the heart of Europe and both building political cachet as they supply those scrambling for shots on the bloc's fringes.
Vaccines produced in Russia and China are already on the program in parts of the Balkans and Eastern Europe outside the European Union.
Speaking to the Atlantic Council on Thursday, Macron called China’s vaccine efforts a “clear diplomatic success” which is “a little bit humiliating for us.” He and German Chancellor Angela Merkel have expressed their openness to using vaccines from Moscow and Beijing if E.U. regulatory approval is granted.
Read more at: In Europe Union, vaccines from Russia and China are now under study - The Washington Post
Vaccines produced in Russia and China are already on the program in parts of the Balkans and Eastern Europe outside the European Union.
Speaking to the Atlantic Council on Thursday, Macron called China’s vaccine efforts a “clear diplomatic success” which is “a little bit humiliating for us.” He and German Chancellor Angela Merkel have expressed their openness to using vaccines from Moscow and Beijing if E.U. regulatory approval is granted.
Read more at: In Europe Union, vaccines from Russia and China are now under study - The Washington Post
Labels:
Alternative,
China,
EU,
Russian,
Vaccinations,
Vaccines
Friday, January 29, 2021
EU approves AstraZeneca coronavirus vaccine
COVID-19 Vaccine AstraZeneca is now authorised across the EU. This follows the granting of a conditional marketing authorisation by the European Commission on 29 January 2021.
EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. This is the third COVID-19 vaccine that EMA has recommended for authorisation.
EMA’s human medicines committee (CHMP) has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission. This will assure EU citizens that the vaccine meets EU standards and puts in place the safeguards, controls and obligations to underpin EU-wide vaccination campaigns.
Read more at: EU approves AstraZeneca coronavirus vaccine | News | DW | 29.01.2021
EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. This is the third COVID-19 vaccine that EMA has recommended for authorisation.
EMA’s human medicines committee (CHMP) has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission. This will assure EU citizens that the vaccine meets EU standards and puts in place the safeguards, controls and obligations to underpin EU-wide vaccination campaigns.
Read more at: EU approves AstraZeneca coronavirus vaccine | News | DW | 29.01.2021
Labels:
Approves,
AstraZeneca,
EU,
Vaccines
Subscribe to:
Posts (Atom)